2022
DOI: 10.3390/biomedicines10061434
|View full text |Cite
|
Sign up to set email alerts
|

Urinary MicroRNA Sensing Using Electrochemical Biosensor to Evaluate Colorectal Cancer Progression

Abstract: Research in cancer diagnostics has recently established its footing and significance in the biosensor sphere, emphasizing the idea of a unique probe design used as a sensor and actuator, to identify the presence of protein, DNA, RNA, or miRNA. The fluorescein isothiocyanate (FITC) probe and biotinylated probe are designed for a two-pronged approach to the detection of the urinary miR-21 and miR-141, both of which have demonstrated significance in the development and progression of colorectal cancer, a leading … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 49 publications
0
3
0
Order By: Relevance
“…Depending on the detection target, different metals, enzymes, complexing agents, polymers, etc., are added to adjust the composition of the ink. The results obtained with proposed exomiR biosensor were compared with previous reports [ 17 , 27 , 32 ], and we optimized the surface of the SPCE with minor modification of the biotin-binding protein Streptavidin to NeutrAvidin, then applied it to real clinical urine samples from PCa patients, which considerably increased affinity of the probe, as well as the stability of the platform. The proposed exomiR biosensor could significantly improve the clinical screening of PCa patients, which, to date, has relied on invasive methods to collect serum to detect PSA.…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…Depending on the detection target, different metals, enzymes, complexing agents, polymers, etc., are added to adjust the composition of the ink. The results obtained with proposed exomiR biosensor were compared with previous reports [ 17 , 27 , 32 ], and we optimized the surface of the SPCE with minor modification of the biotin-binding protein Streptavidin to NeutrAvidin, then applied it to real clinical urine samples from PCa patients, which considerably increased affinity of the probe, as well as the stability of the platform. The proposed exomiR biosensor could significantly improve the clinical screening of PCa patients, which, to date, has relied on invasive methods to collect serum to detect PSA.…”
Section: Discussionmentioning
confidence: 97%
“…The SPCE surface was designed according to our previous study on urinary miRNA sensing in colorectal cancer, with further optimizations [ 27 ]. In brief, we used 50 μL of CMD-Na (50 mg/mL) to generate a carboxylic (COOH) functional group on the SPCE surface and dipped it into a solution of 8 mg/mL 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and 22 mg/mL N-hydroxysulfosuccinimide (NHS) in a 0.1 M MES buffer (pH 4.7) for 15 min at room temperature in order to activate the COOH, resulting in a stable RC=O-NH-R 2 bond, which allows NeutrAvidin to bind covalently.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation